Targeted downregulation of N‐acetylgalactosamine 4‐sulfate 6‐O‐sulfotransferase significantly mitigates chondroitin sulfate proteoglycan‐mediated inhibition
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Chondroitin sulfate‐4,6 (CS‐E) glycosaminoglycan (GAG) upregulation in astroglial scars is a major contributor to chondroitin sulfate proteoglycan (CSPG)‐mediated inhibition [Gilbert et al. (2005) Mol Cell Neurosci 29:545–558]. However, the role of N‐acetylgalactosamine 4‐sulfate 6‐O‐sulfotransferase (GalNAc4S6ST) catalyzed sulfation of CS‐E, and its contribution to CSPG‐mediated inhibition of CNS regeneration remains to be fully elucidated. Here, we used in situ hybridization to show localized upregulation of GalNAc4S6ST mRNA after CNS injury. Using in vitro spot assays with immobilized CS‐E, we demonstrate dose‐dependent inhibition of rat embryonic day 18 (E18) cortical neurons. To determine whether selective downregulation of CS‐E affected the overall inhibitory character of extracellular matrix produced by reactive astrocytes, single [against (chondroitin 4) sulfotransferase 11 (C4ST1) or GalNAc4S6ST mRNA] or double [against C4ST1 and GalNAc4S6ST mRNA] siRNA treatments were conducted and assayed using quantitative real‐time polymerase chain reaction and high‐performance liquid chromatography to confirm the specific downregulation of CS‐4S GAG (CS‐A) and CS‐E. Spot and Bonhoeffer stripe assays using astrocyte‐conditioned media from siRNA‐treated rat astrocytes showed a significant decrease in inhibition of neuronal attachment and neurite extensions when compared with untreated and TGFα‐treated astrocytes. These findings reveal that selective attenuation of CS‐E via siRNA targeting of GalNAc4S6ST significantly mitigates CSPG‐mediated inhibition of neurons, potentially offering a novel intervention strategy for CNS injury. © 2011 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357 · cited 1×
“Further, chondroitinase ABC (chABC) treatment of the glial scar resulted in significant enhancement of neurite outgrowth (Becker and Becker, 2002; Bradbury et al., 2002; Lee et al., 2009; McKeon et al., 1995).”
BackgroundPTPσ Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration
Shen, Y., Tenney, A. P., Busch, S. A., Horn, K. P., Cuascut, F. X., Liu, K., He, Z., Silver, J., & Flanagan, J. G. (2009) · Science · doi:10.1126/science.1178310 · Cited by 682
Galtrey, C. M., & Fawcett, J. W. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.006 · Cited by 575
Composition of Perineuronal Net Extracellular Matrix in Rat Brain
Deepa, S. S., Carulli, D., Galtrey, C., Rhodes, K., Fukuda, J., Mikami, T., Sugahara, K., & Fawcett, J. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600544200 · Cited by 367
Chondroitin-4-sulfation negatively regulates axonal guidance and growth
Wang, H., Katagiri, Y., McCann, T. E., Unsworth, E., Goldsmith, P., Yu, Z.-X., Tan, F., Santiago, L., Mills, E. M., Wang, Y., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.032649 · Cited by 243 · cited 2×
“More recent evidence demonstrates that CS-A is a negative regulator of axonal growth (Wang et al., 2008).”
BackgroundGrowth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes
Smith, G. M., & Strunz, C. (2005) · Glia · doi:10.1002/glia.20236 · Cited by 174
Chondroitin sulfate E promotes neurite outgrowth of rat embryonic day 18 hippocampal neurons
Clement, A. M., Sugahara, K., & Faissner, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00432-2 · Cited by 127
Chondroitin sulfate proteoglycans in neural development and plasticity
Maeda, N. (2010) · Frontiers in Bioscience · doi:10.2741/3637 · Cited by 44
Cited by
Pathophysiology of the brain extracellular matrix: a new target for remyelination
Lau, L. W., Cua, R., Keough, M. B., Haylock-Jacobs, S., & Yong, V. W. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3550 · Cited by 549
Restoring function after spinal cord injury: towards clinical translation of experimental strategies
Ramer, L. M., Ramer, M. S., & Bradbury, E. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70144-9 · Cited by 324
Chondroitin sulfate glycosaminoglycan hydrogels create endogenous niches for neural stem cells
Karumbaiah, L., Enam, S. F., Brown, A. C., Saxena, T., Betancur, M. I., Barker, T. H., & Bellamkonda, R. V. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00397 · Cited by 73
Self-citationFlexible Roles for Proteoglycan Sulfation and Receptor Signaling
Yu, P., Pearson, C. S., & Geller, H. M. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2017.10.005 · Cited by 67
Alonge, K. M., Logsdon, A. F., Murphree, T. A., Banks, W. A., Keene, C. D., Edgar, J. S., Whittington, D., Schwartz, M. W., & Guttman, M. (2019) · Glycobiology · doi:10.1093/glycob/cwz060 · Cited by 38
Metadata
- Authors
- Karumbaiah, L., Anand, S., Thazhath, R., Zhong, Y., Mckeon, R. J., & Bellamkonda, R. V.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2011-03-31
- Volume
- 59
- Issue
- 6
- Pages
- 981-996
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2095262864
- Cited by
- 52
- References
- 8
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeted downregulation of N‐acetylgalactosamine 4‐sulfate 6‐O‐sulfotransferase significantly mitigates chondroitin sulfate proteoglycan‐mediated inhibition. https://app.cochat.ai/papers/10.1002/glia.21170
- The paper
- Karumbaiah, L., Anand, S., Thazhath, R., Zhong, Y., Mckeon, R. J., & Bellamkonda, R. V. (2011). Targeted downregulation of N‐acetylgalactosamine 4‐sulfate 6‐O‐sulfotransferase significantly mitigates chondroitin sulfate proteoglycan‐mediated inhibition. Glia. https://doi.org/10.1002/glia.21170
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.